Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sachin Punatar

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Journal of Cancer Research and Therapeutics|September 11, 2018
Lomustine, cytarabine, cyclophosphamide, etoposide - An effective conditioning regimen in autologous hematopoietic stem cell transplant for primary refractory or relapsed lymphoma: Analysis of toxicity, long-term outcome, and prognostic factorsAlok Gupta, Anant Gokarn, Deepan Rajamanickam, et al.
American Journal of Blood Research|November 26, 2021
Human leukocyte antigen (HLA) alleles as predictive factors for benefit from lenalidomide in acute myeloid leukemia (AML)Sachin Punatar, Anant Gokarn, Lingaraj Nayak, et al.
Cancer Biomarkers : Section a of Disease Markers|August 2, 2021
CD26 expression on donor harvest as a risk predictive biomarker for developing graft-versus-host disease post-allogeneic hematopoietic stem cell transplantation: A ten-year follow-up studySachin Punatar, Shruti Kandekar, Navin Khattry, et al.
American Journal of Blood Research|November 26, 2021
Long term outcome of a patient with relapsed refractory early thymic precursor acute lymphoblastic leukemia treated with daratumumabSachin Punatar, Anant Gokarn, Lingaraj Nayak, et al.
Blood Research|January 16, 2018
Is long term storage of cryopreserved stem cells for hematopoietic stem cell transplantation a worthwhile exercise in developing countries?Santhosh Kumar Devadas, Minal Khairnar, Sumathi S Hiregoudar, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 29, 2018
Antibiotic lock therapy for salvage of tunneled central venous catheters with catheter colonization and catheter-related bloodstream infectionSaurabh Zanwar, Punit Jain, Anant Gokarn, et al.
Blood Cell Therapy|June 9, 2025
Tyrosine kinase inhibitor-related factors pre-disposing to post-transplant thrombotic microangiopathy in patients with CML and Ph+ acute leukemiasSachin Punatar, Komal Kumbhalwar, Siddhesh A Kalantri, et al.
Transfusion Medicine (Oxford, England)|May 4, 2026
Isoagglutinin dynamics and transfusion dependency after ABO-incompatible haematopoietic stem cell transplantsC C Archana, Suryatapa Saha, Shashank Ojha, et al.
Bone Marrow Transplantation|January 30, 2021
Pre-transplant use of tyrosine kinase inhibitors and transplant associated thrombotic microangiopathy - a single centre analysis of incidence, risk factors and outcomesSachin Punatar, Siddhesh A Kalantri, Akanksha Chichra, et al.
The Indian Journal of Medical Research|August 12, 2021
Role of cytogenetic abnormalities detected by fluorescence <i>in situ</i> hybridization as a prognostic marker: Pathogenesis & clinical course in patients with B-chronic lymphocytic leukaemiaDhanlaxmi Shetty, Hemani Jain, Yogita Rohil, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Journal of Cancer Research and Therapeutics|September 11, 2018
Lomustine, cytarabine, cyclophosphamide, etoposide - An effective conditioning regimen in autologous hematopoietic stem cell transplant for primary refractory or relapsed lymphoma: Analysis of toxicity, long-term outcome, and prognostic factorsAlok Gupta, Anant Gokarn, Deepan Rajamanickam, et al.
American Journal of Blood Research|November 26, 2021
Human leukocyte antigen (HLA) alleles as predictive factors for benefit from lenalidomide in acute myeloid leukemia (AML)Sachin Punatar, Anant Gokarn, Lingaraj Nayak, et al.
Cancer Biomarkers : Section a of Disease Markers|August 2, 2021
CD26 expression on donor harvest as a risk predictive biomarker for developing graft-versus-host disease post-allogeneic hematopoietic stem cell transplantation: A ten-year follow-up studySachin Punatar, Shruti Kandekar, Navin Khattry, et al.
American Journal of Blood Research|November 26, 2021
Long term outcome of a patient with relapsed refractory early thymic precursor acute lymphoblastic leukemia treated with daratumumabSachin Punatar, Anant Gokarn, Lingaraj Nayak, et al.
Blood Research|January 16, 2018
Is long term storage of cryopreserved stem cells for hematopoietic stem cell transplantation a worthwhile exercise in developing countries?Santhosh Kumar Devadas, Minal Khairnar, Sumathi S Hiregoudar, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 29, 2018
Antibiotic lock therapy for salvage of tunneled central venous catheters with catheter colonization and catheter-related bloodstream infectionSaurabh Zanwar, Punit Jain, Anant Gokarn, et al.
Blood Cell Therapy|June 9, 2025
Tyrosine kinase inhibitor-related factors pre-disposing to post-transplant thrombotic microangiopathy in patients with CML and Ph+ acute leukemiasSachin Punatar, Komal Kumbhalwar, Siddhesh A Kalantri, et al.
Transfusion Medicine (Oxford, England)|May 4, 2026
Isoagglutinin dynamics and transfusion dependency after ABO-incompatible haematopoietic stem cell transplantsC C Archana, Suryatapa Saha, Shashank Ojha, et al.
Bone Marrow Transplantation|January 30, 2021
Pre-transplant use of tyrosine kinase inhibitors and transplant associated thrombotic microangiopathy - a single centre analysis of incidence, risk factors and outcomesSachin Punatar, Siddhesh A Kalantri, Akanksha Chichra, et al.
The Indian Journal of Medical Research|August 12, 2021
Role of cytogenetic abnormalities detected by fluorescence <i>in situ</i> hybridization as a prognostic marker: Pathogenesis & clinical course in patients with B-chronic lymphocytic leukaemiaDhanlaxmi Shetty, Hemani Jain, Yogita Rohil, et al.
Pageof 7